Named Patient Programs (“NPP”) is one of the
exceptional importation regimes of pharmaceuticals without
marketing authorization (“MA”) in Turkey, or with
marketing authorization, but which are unavailable in the Turkish
market for various reasons.
In cases where a pharmaceutical does not have an MA in Turkey,
or has an MA, but cannot be found on the market, and patients are
in need the pharmaceutical in question, it is possible to procure
the pharmaceutical via this special method upon the request of a
physician. Institutions authorized to import pharmaceuticals within
the scope of the supply of pharmaceuticals from abroad are
Uluslararası Sağlık Hizmetleri A.Ş.
(“USHAŞ”), Turkish Pharmacists' Association
(“TEB”) and /or the İbn-i Sina Health Social
Security Center (“İbn-i Sina”), within the Social
Security Institution (“SSI”).
